iRadimed (NASDAQ:IRMD) reported its Q4 earnings results on Friday, February 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
iRadimed beat estimated earnings by 57.14%, reporting an EPS of $0.33 versus an estimate of $0.21, which surprised analysts.
Also check this: Executives Buy More Than $28M Of 4 Stocks
Revenue was up $3.33 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06, which was followed by a 3.09% increase in the share price the next day.
Here's a look at iRadimed's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.17 | 0.09 | 0.10 | 0.10 |
| EPS Actual | 0.23 | 0.14 | 0.13 | 0.07 |
| Revenue Estimate | 10.40M | 8.46M | 8.56M | 8.44M |
| Revenue Actual | 10.91M | 9.81M | 9.22M | 8.55M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
